Literature DB >> 19428507

Endothelin-1 induced MCAO: dose dependency of cerebral blood flow.

Simona Nikolova1, Slavianka Moyanova, Sarah Hughes, Miranda Bellyou-Camilleri, Ting-Yim Lee, Robert Bartha.   

Abstract

The purpose of this study was to characterize the magnitude and duration of cerebral blood flow (CBF) reduction in the somatosensory cortical region in a rat model of middle cerebral artery occlusion (MCAO) induced by endothelin-1 (ET1) microinjection under isoflurane anesthesia. MCAO was induced by microinjection of ET1 proximal to the MCA in 41 isoflurane-anesthetized male Sprague-Dawley rats. Three doses of ET1 were studied, 60 pmol (Group 1), 150 pmol (Group 2), and 300 pmol (Group 3). CBF was monitored for 4h following injection using a laser Doppler probe stereotaxically inserted into the left somatosensory cortical region. Computed tomography perfusion imaging was used to verify the extent and duration of blood flow reduction in a subset of 12 animals. The magnitude and duration of blood flow reduction was variable (60-92% of baseline). The 300 pmol dose provided the greatest sustained decrease in blood flow. Evidence of tissue damage was obtained in cases where CBF decreased to <40% of baseline. At the doses studied, ET1-induced ischemia in the presence of isoflurane anesthesia can be used as a minimally invasive but variable model of MCAO. The model is well suited for acute imaging studies of ischemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428507     DOI: 10.1016/j.jneumeth.2009.01.009

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  10 in total

1.  Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct Core.

Authors:  Christopher D d'Esterre; Richard I Aviv; Laura Morrison; Enrico Fainardi; Ting Yim Lee
Journal:  Transl Stroke Res       Date:  2015-04-15       Impact factor: 6.829

2.  Long-term survival and serial assessment of stroke damage and recovery - practical and methodological considerations.

Authors:  Michel Modo
Journal:  J Exp Stroke Transl Med       Date:  2009-01

3.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

Review 4.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

Review 5.  Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia.

Authors:  I M Macrae
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.

Authors:  Huong L Moldthan; Aaron C Hirko; Jeffrey S Thinschmidt; Maria B Grant; Zhimin Li; Joanna Peris; Yuanqing Lu; Ahmed S Elshikha; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-02-28       Impact factor: 2.136

7.  A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic stroke.

Authors:  Jessica Mary Livingston-Thomas; Andrew Wilson Hume; Tracy Ann Doucette; Richard Andrew Tasker
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

8.  Comparative Therapeutic Effects of Minocycline Treatment and Bone Marrow Mononuclear Cell Transplantation following Striatal Stroke.

Authors:  Celice C Souza; Michelle Castro da Silva; Rosana Telma Lopes; Marcelo M Cardoso; Lucas Lacerda de Souza; Adriano Guimarães Santos; Ijair Rogério Dos Santos; Edna C S Franco; Walace Gomes-Leal
Journal:  Oxid Med Cell Longev       Date:  2017-06-21       Impact factor: 6.543

9.  Absolute Cerebral Blood Flow Infarction Threshold for 3-Hour Ischemia Time Determined with CT Perfusion and 18F-FFMZ-PET Imaging in a Porcine Model of Cerebral Ischemia.

Authors:  Eric A Wright; Christopher D d'Esterre; Laura B Morrison; Neil Cockburn; Michael Kovacs; Ting-Yim Lee
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

10.  No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intake.

Authors:  Sigurdur T Sigurdsson; Peter Bie; Arne H Nielsen; Svend Strandgaard; Olaf B Paulson
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2019 Jul-Sep       Impact factor: 1.636

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.